Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Jul 11, 2025

Accession no.
0001628280-25-034818
Filed
Jul 11, 2025
Trade date
Jun 2-30, 2025
Filing delay
39 daysLate
Rule 10b5-1 plan
Checked

This filing lists 20 non-derivative transactions and 0 derivative transactions. Open-market purchases total $807.2. It was filed 39 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 2, 2025Common StockPPurchaseAcquired+8$5.20+$41.65,699,268Direct
Jun 3, 2025Common StockPPurchaseAcquired+8$5.61+$44.885,699,276Direct
Jun 4, 2025Common StockPPurchaseAcquired+8$5.75+$465,699,284Direct
Jun 5, 2025Common StockPPurchaseAcquired+8$5.46+$43.685,699,292Direct
Jun 6, 2025Common StockPPurchaseAcquired+8$5.57+$44.565,699,300Direct
Jun 9, 2025Common StockPPurchaseAcquired+8$5.94+$47.525,699,308Direct
Jun 10, 2025Common StockPPurchaseAcquired+8$6.00+$485,699,316Direct
Jun 11, 2025Common StockPPurchaseAcquired+8$5.57+$44.565,699,324Direct
Jun 12, 2025Common StockPPurchaseAcquired+8$5.67+$45.365,699,332Direct
Jun 13, 2025Common StockPPurchaseAcquired+8$5.81+$46.485,699,340Direct
Jun 16, 2025Common StockPPurchaseAcquired+8$5.32+$42.565,699,348Direct
Jun 17, 2025Common StockPPurchaseAcquired+8$5.61+$44.885,699,356Direct
Jun 18, 2025Common StockPPurchaseAcquired+8$5.52+$44.165,699,364Direct
Jun 20, 2025Common StockPPurchaseAcquired+8$5.29+$42.325,699,372Direct
Jun 23, 2025Common StockPPurchaseAcquired+8$4.61+$36.885,699,380Direct
Jun 24, 2025Common StockPPurchaseAcquired+8$3.91+$31.285,699,388Direct
Jun 25, 2025Common StockPPurchaseAcquired+8$3.27+$26.165,699,396Direct
Jun 26, 2025Common StockPPurchaseAcquired+8$2.71+$21.685,699,404Direct
Jun 27, 2025Common StockPPurchaseAcquired+8$2.60+$20.85,699,412Direct
Jun 30, 2025Common StockPPurchaseAcquired+16$2.74+$43.845,699,428Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)